Recently CEO of Amreteck Pharma was interviewed by various newspapers in Europe and Bangladesh and he emphasis on medicines manufacturing outsource to Bangladesh.
See below few of them:
1)Shortcut to: http://www.outsourcing-pharma.com/On-your-radar/Globalisation/Bangladesh...
2) Shortcut to: http://www.thedailystar.net/newDesign/news-details.php?nid=110613
3)Shortcut to: http://nation.ittefaq.com/issues/2009/09/08/news0851.htm
Regards,
Amreteck Pharma LLC, USA
www.amreteckpharma.com/demo1
Email: info@amreteckpharma.com
Mr. Altaf
Since it sounds like you have grown with Chor Tareq, what we can expect from people like you. All you see Dhandabaz since you live with a Dhandabaz!
গান গাইবেননা ভাই
ধান্ধবাজদের চামড়া
তুলে নেব আমরা
NRB Investor(s) Seminar is coming soon
Amreteck® Pharma's will conduct series of investor(s) seminar at the following counties in 2010. Actual seminar dates will be posted soon.
These seminar(s) will help to educate potential individual and or institutional investors including NBR (non-resident Bangladeshi) living in various countries in the world about pontential benefit in investing at the Pharmaceuticals sector in Bangladesh. These seminars will give an opportunity to perform an Q & A session.
Amreteck® Pharma also will provide a snaphot of its future projects in Bangladesh where approx. US$11.5MM will be needed to complete these projects in the next 3 years. The following Amreteck® Pharma projects where NRB investment will have better investment return:
More detail about these projects will be available soon.
Current plan on conducting seminar(s):
1) USA, New York - Feb 2010
2) Canada, Toronto - March 2010
3) UK, London - April 2010
4) UAE, Dhubai - May 2010
5) Qatar, Doha - June 2010
6) Bangladesh, Dhaka - July 2010
Note: Dates can be changed as approrpiate. Advertisment will be in the media about the upcoming NRB Investor(s) seminars in the above countries.
--------------------------------------------------------------------------------------------------------------------------
Amreteck® Future Projects
Independent Chemical/Stability Testing Lab (Year 2010): Projected Cost: $3.5MM
Amreteck® plans to open “Independent Chemical/Stability Testing Lab” in Bangladesh:
v Provide Bio-equivalency study for the Pharmaceutical companies. Bioequivalency study is a pre-requisite for exporting any medicines to foreign countries
v Provide lab testing for Assay, API, Identification, TOC, Conductivity, metal, iron, total particulates, micro, PE, density, viscosity, pH, stability, and others.
v This lab is one stop service for all of your testing
v This lab also works for the products buyer(s) who want to get COAs by an independent lab before shipping its products.
v Stability sample storage and testing
v Lab testing service is provided to Pharmaceutical, food and drink industries.
Drugs Clinical Trials Services (Year 2011): Projected Cost US$3MM
Amreteck® plans to open “Drugs Clinical Trials Services” in Bangladesh:
v Amreteck Clinical services will provide patient enrollment, provide drug dosage, monitor patients for the drugs reaction and submit results to the client.
v This service includes providing up to 18 months drugs reaction data to the client.
Pathology, Lab and Health Services (Year 2012): Projected Cost US$5MM
Amreteck® believes in quality health services and patient care and plans to open “Pathology, Lab and Health Services” units in USA and Bangladesh to meet growing needs for the quality care.
আহা রে!
দুনিয়াটা ধান্ধাবাজে ভইরা গেছে!